How CancerIQ helps Adventist Health identify high-risk patients to reduce hereditary cancer deaths
Jul 3, 2019
As an OB-GYN, Dr. Candace Westgate has those days when she must deliver bad news—a cancer diagnosis—to a patient.
But in recent years, some of those cases have come using genetic testing to identify high-risk patients earlier to preempt or prevent the disease.
It’s one of the reasons Westgate became a champion of the Early All-Around Detection (AHEAD) Program at Adventist Health, the 21 hospital-based health system where she works in St. Helena, California. Adventist Health operates hospitals in California, Oregon, and Hawaii.
Read the full story by Heather Landi on FierceHealthcare.
Related articles
Technology & Innovation, Press Releases
St. Helena Hospital's Cardiac Surgery Team Completes Groundbreaking Surgical Procedure in Atrial Fibrillation Study Marking a Historic First in the Nation
Technology & Innovation
St. Helena Hospital Introduces Leading-Edge Cardiac Imaging with HeartFlow